Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease

Neurobiology of Aging

Volumn 44, Issue , 2016, Pages 185-196

  Rosen, Rebecca F ^a,e   Tomidokoro, Yasushi ^b,g   Farberg, Aaron S ^a,f   Dooyema, Jeromy ^a   Ciliax, Brian ^c   Preuss, Todd M ^a,c   Neubert, Thomas A ^b   Ghiso, Jorge A ^b   LeVine, Harry ^d   Walker, Lary C ^a,c  

^a EMORY UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f National Society for Cutaneous Medicine   (United States)

^g UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Amyloid; Cerebral amyloid angiopathy; Primate; Prion; Seeding; Senile plaques; Tauopathy

Indexed keywords

AMYLOID BETA PROTEIN; DODECYL SULFATE SODIUM; OLIGOMER; PITTSBURGH COMPOUND B;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOUSE; NEOCORTEX; NONHUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN AGGREGATION; SAIMIRI SCIUREUS; TAUOPATHY; TEMPORAL CORTEX; VERY ELDERLY; AGING; ANIMAL; BRAIN; DISEASE MODEL; METABOLISM; PATHOLOGY; SQUIRREL MONKEY; TAUOPATHIES; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; HUMANS; MICE, TRANSGENIC; SAIMIRI; TAUOPATHIES;

EID: 84989848524     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.04.019     Document Type: Article

References (123)

1. Alexandru, A., Jagla, W., Graubner, S., Becker, A., Bauscher, C., Kohlmann, S., Sedlmeier, R., Raber, K.A., Cynis, H., Ronicke, R., Reymann, K.G., Petrasch-Parwez, E., Hartlage-Rubsamen, M., Waniek, A., Rossner, S., Schilling, S., Osmand, A.P., Demuth, H.U., von Horsten, S., Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Abeta is induced by pyroglutamate-Abeta formation. J. Neurosci. 31 (2011), 12790–12801.
2. Arriagada, P.V., Marzloff, K., Hyman, B.T., Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42 (1992), 1681–1688.
3. Bakota, L., Brandt, R., Tau biology and tau-directed therapies for Alzheimer's disease. Drugs 76 (2016), 301–313.
4. Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., Fox, N.C., Marcus, D.S., Cairns, N.J., Xie, X., Blazey, T.M., Holtzman, D.M., Santacruz, A., Buckles, V., Oliver, A., Moulder, K., Aisen, P.S., Ghetti, B., Klunk, W.E., McDade, E., Martins, R.N., Masters, C.L., Mayeux, R., Ringman, J.M., Rossor, M.N., Schofield, P.R., Sperling, R.A., Salloway, S., Morris, J.C., Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367 (2012), 795–804.
5. Becker, A., Kohlmann, S., Alexandru, A., Jagla, W., Canneva, F., Bauscher, C., Cynis, H., Sedlmeier, R., Graubner, S., Schilling, S., Demuth, H.U., von Horsten, S., Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration. BMC Neurosci., 14, 2013, 108.
6. Bierer, L.M., Hof, P.R., Purohit, D.P., Carlin, L., Schmeidler, J., Davis, K.L., Perl, D.P., Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52 (1995), 81–88.
7. Bilousova, T., Miller, C.A., Poon, W.W., Vinters, H.V., Corrada, M., Kawas, C., Hayden, E.Y., Teplow, D.B., Glabe, C., Albay, R. 3rd, Cole, G.M., Teng, E., Gylys, K.H., Synaptic amyloid-beta oligomers precede p-tau and differentiate high pathology control cases. Am. J. Pathol. 186 (2016), 185–198.
8. Bitan, G., Fradinger, E.A., Spring, S.M., Teplow, D.B., Neurotoxic protein oligomers—what you see is not always what you get. Amyloid 12 (2005), 88–95.
9. Bitan, G., Kirkitadze, M.D., Lomakin, A., Vollers, S.S., Benedek, G.B., Teplow, D.B., Amyloid beta -protein (Abeta) assembly: abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 330–335.
10. Borchelt, D.R., Ratovitski, T., van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Copeland, N.G., Price, D.L., Sisodia, S.S., Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 (1997), 939–945.
11. Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 (1991), 239–259.
12. Buchhave, P., Minthon, L., Zetterberg, H., Wallin, A.K., Blennow, K., Hansson, O., Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiatry 69 (2012), 98–106.
13. Catalano, S.M., Dodson, E.C., Henze, D.A., Joyce, J.G., Krafft, G.A., Kinney, G.G., The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Curr. Top Med. Chem. 6 (2006), 597–608.
14. Chang, Y.J., Chen, Y.R., The coexistence of an equal amount of Alzheimer's amyloid-beta 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway. FEBS J. 281 (2014), 2674–2687.
15. Chen, X., Errangi, B., Li, L., Glasser, M.F., Westlye, L.T., Fjell, A.M., Walhovd, K.B., Hu, X., Herndon, J.G., Preuss, T.M., Rilling, J.K., Brain aging in humans, chimpanzees (Pan troglodytes), and rhesus macaques (Macaca mulatta): magnetic resonance imaging studies of macro- and microstructural changes. Neurobiol. Aging 34 (2013), 2248–2260.
16. Cohen, M.L., Kim, C., Haldiman, T., ElHag, M., Mehndiratta, P., Pichet, T., Lissemore, F., Shea, M., Cohen, Y., Chen, W., Blevins, J., Appleby, B.S., Surewicz, K., Surewicz, W.K., Sajatovic, M., Tatsuoka, C., Zhang, S., Mayo, P., Butkiewicz, M., Haines, J.L., Lerner, A.J., Safar, J.G., Rapidly progressive Alzheimer's disease features distinct structures of amyloid-beta. Brain 138 (2015), 1009–1022.
17. Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., Wolfson, L., Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38 (1988), 1682–1687.
18. D'Angelo, O.M., Dooyema, J., Courtney, C., Walker, L.C., Heuer, E., Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys). Comp. Med. 63 (2013), 515–520.
19. Eisele, Y.S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L.H., Yan, Z.X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L.C., Jucker, M., Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 12926–12931.
20. Eisele, Y.S., Obermuller, U., Heilbronner, G., Baumann, F., Kaeser, S.A., Wolburg, H., Walker, L.C., Staufenbiel, M., Heikenwalder, M., Jucker, M., Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330 (2010), 980–982.
21. Elfenbein, H.A., Rosen, R.F., Stephens, S.L., Switzer, R.C., Smith, Y., Pare, J., Mehta, P.D., Warzok, R., Walker, L.C., Cerebral beta-amyloid angiopathy in aged squirrel monkeys. Histol. Histopathol. 22 (2007), 155–167.
22. Fast, R., Rodell, A., Gjedde, A., Mouridsen, K., Alstrup, A.K., Bjarkam, C.R., West, M.J., Berendt, M., Moller, A., PiB fails to map amyloid deposits in cerebral cortex of aged dogs with canine cognitive dysfunction. Front. Aging Neurosci., 5, 2013, 99.
23. Ferreira, S.T., Lourenco, M.V., Oliveira, M.M., De Felice, F.G., Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front. Cell Neurosc., 9, 2015, 191.
24. Finch, C.E., Austad, S.N., Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging. Age (Dordr) 34 (2012), 1075–1091.
25. Finch, C.E., Austad, S.N., Commentary: is Alzheimer's disease uniquely human?. Neurobiol. Aging 36 (2015), 553–555.
26. Finch, C.E., Sapolsky, R.M., The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol. Aging 20 (1999), 407–428.
27. Forny-Germano, L., Lyra e Silva, N.M., Batista, A.F., Brito-Moreira, J., Gralle, M., Boehnke, S.E., Coe, B.C., Lablans, A., Marques, S.A., Martinez, A.M., Klein, W.L., Houzel, J.C., Ferreira, S.T., Munoz, D.P., De Felice, F.G., Alzheimer's disease-like pathology induced by amyloid-beta oligomers in nonhuman primates. J. Neurosci. 34 (2014), 13629–13643.
28. Franklin, K.B.J., Paxinos, G., The mouse brain in stereotaxic coordinates. third ed., 2007, Elsevier, Amsterdam, Oxford.
29. Fritschi, S.K., Cintron, A., Ye, L., Mahler, J., Buhler, A., Baumann, F., Neumann, M., Nilsson, K.P., Hammarstrom, P., Walker, L.C., Jucker, M., Abeta seeds resist inactivation by formaldehyde. Acta Neuropathol. 128 (2014), 477–484.
30. Gearing, M., Tigges, J., Mori, H., Mirra, S.S., A beta40 is a major form of beta-amyloid in nonhuman primates. Neurobiol. Aging 17 (1996), 903–908.
31. Gearing, M., Tigges, J., Mori, H., Mirra, S.S., beta-Amyloid (A beta) deposition in the brains of aged orangutans. Neurobiol. Aging 18 (1997), 139–146.
32. Geula, C., Nagykery, N., Wu, C.K., Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol. (Berl) 103 (2002), 48–58.
33. Gillman, A.L., Jang, H., Lee, J., Ramachandran, S., Kagan, B.L., Nussinov, R., Teran Arce, F., Activity and architecture of pyroglutamate-modified amyloid-beta (AbetapE3-42) pores. J. Phys. Chem. B 118 (2014), 7335–7344.
34. Hamaguchi, T., Eisele, Y.S., Varvel, N.H., Lamb, B.T., Walker, L.C., Jucker, M., The presence of Abeta seeds, and not age per se, is critical to the initiation of Abeta deposition in the brain. Acta Neuropathol. 123 (2012), 31–37.
35. Hamley, I.W., The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. Chem. Rev. 112 (2012), 5147–5192.
36. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
37. Hatami, A., Albay, R. 3rd, Monjazeb, S., Milton, S., Glabe, C., Monoclonal antibodies against Abeta42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J. Biol. Chem. 289 (2014), 32131–32143.
38. Head, E., A canine model of human aging and Alzheimer's disease. Biochim. Biophys. Acta 1832 (2013), 1384–1389.
39. Heilbronner, G., Eisele, Y.S., Langer, F., Kaeser, S.A., Novotny, R., Nagarathinam, A., Aslund, A., Hammarstrom, P., Nilsson, K.P., Jucker, M., Seeded strain-like transmission of beta-amyloid morphotypes in APP transgenic mice. EMBO Rep. 14 (2013), 1017–1022.
40. Hepler, R.W., Grimm, K.M., Nahas, D.D., Breese, R., Dodson, E.C., Acton, P., Keller, P.M., Yeager, M., Wang, H., Shughrue, P., Kinney, G., Joyce, J.G., Solution state characterization of amyloid beta-derived diffusible ligands. Biochemistry 45 (2006), 15157–15167.
41. Herndon, J.G., Tigges, J., Anderson, D.C., Klumpp, S.A., McClure, H.M., Brain weight throughout the life span of the chimpanzee. J. Comp. Neurol. 409 (1999), 567–572.
42. Herndon, J.G., Tigges, J., Klumpp, S.A., Anderson, D.C., Brain weight does not decrease with age in adult rhesus monkeys. Neurobiol. Aging 19 (1998), 267–272.
43. Heuer, E., Rosen, R.F., Cintron, A., Walker, L.C., Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr. Pharm. Des. 18 (2012), 1159–1169.
44. Holtzman, D.M., Morris, J.C., Goate, A.M., Alzheimer's disease: the challenge of the second century. Sci. Transl. Med., 3, 2011, 77sr1.
45. Ikonomovic, M.D., Abrahamson, E.E., Price, J.C., Hamilton, R.L., Mathis, C.A., Paljug, W.R., Debnath, M.L., Cohen, A.D., Mizukami, K., DeKosky, S.T., Lopez, O.L., Klunk, W.E., Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathol. 123 (2012), 433–447.
46. Jack, C.R. Jr., Holtzman, D.M., Biomarker modeling of Alzheimer's disease. Neuron 80 (2013), 1347–1358.
47. Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9 (2010), 119–128.
48. Jan, A., Gokce, O., Luthi-Carter, R., Lashuel, H.A., The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283 (2008), 28176–28189.
49. Jonson, M., Pokrzywa, M., Starkenberg, A., Hammarstrom, P., Thor, S., Systematic abeta analysis in Drosophila reveals high toxicity for the 1-42, 3–42 and 11-42 peptides, and emphasizes N- and C-terminal residues. PLoS One, 10, 2015, e0133272.
50. Jucker, M., The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 16 (2010), 1210–1214.
51. Kane, M.D., Lipinski, W.J., Callahan, M.J., Bian, F., Durham, R.A., Schwarz, R.D., Roher, A.E., Walker, L.C., Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J. Neurosci. 20 (2000), 3606–3611.
52. Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D.W., Golde, T., McGowan, E., Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 27 (2007), 627–633.
53. Klunk, W.E., Lopresti, B.J., Ikonomovic, M.D., Lefterov, I.M., Koldamova, R.P., Abrahamson, E.E., Debnath, M.L., Holt, D.P., Huang, G.F., Shao, L., DeKosky, S.T., Price, J.C., Mathis, C.A., Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J. Neurosci. 25 (2005), 10598–10606.
54. Kuo, Y.M., Emmerling, M.R., Vigo-Pelfrey, C., Kasunic, T.C., Kirkpatrick, J.B., Murdoch, G.H., Ball, M.J., Roher, A.E., Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271 (1996), 4077–4081.
55. Kuo, Y.M., Emmerling, M.R., Woods, A.S., Cotter, R.J., Roher, A.E., Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem. Biophys. Res. Commun. 237 (1997), 188–191.
56. Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers-Nolten, I., Van Der Werf, K., Subramaniam, V., Braeken, D., Callewaert, G., Bartic, C., D'Hooge, R., Martins, I.C., Rousseau, F., Schymkowitz, J., De Strooper, B., Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 29 (2010), 3408–3420.
57. Langer, F., Eisele, Y.S., Fritschi, S.K., Staufenbiel, M., Walker, L.C., Jucker, M., Soluble Abeta seeds are potent inducers of cerebral beta-amyloid deposition. J. Neurosci. 31 (2011), 14488–14495.
58. Lemere, C.A., Beierschmitt, A., Iglesias, M., Spooner, E.T., Bloom, J.K., Leverone, J.F., Zheng, J.B., Seabrook, T.J., Louard, D., Li, D., Selkoe, D.J., Palmour, R.M., Ervin, F.R., Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. Am. J. Pathol. 165 (2004), 283–297.
59. Lemere, C.A., Oh, J., Stanish, H.A., Peng, Y., Pepivani, I., Fagan, A.M., Yamaguchi, H., Westmoreland, S.V., Mansfield, K.G., Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?. Rejuvenation Res. 11 (2008), 321–332.
60. Levine, H. 3rd, Walker, L.C., Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol. Aging 31 (2010), 542–548.
61. Lowenson, J.D., Clarke, S., Roher, A.E., Chemical modifications of deposited amyloid-beta peptides. Methods Enzymol. 309 (1999), 89–105.
62. Lu, J.X., Qiang, W., Yau, W.M., Schwieters, C.D., Meredith, S.C., Tycko, R., Molecular structure of beta-amyloid fibrils in Alzheimer's disease brain tissue. Cell 154 (2013), 1257–1268.
63. Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T.C., Suzuki, K., Mori, H., Higuchi, M., Suhara, T., Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J. Neurosci. 27 (2007), 10957–10968.
64. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M.P., Beard, J., Das, P., Jansen, K., Delucia, M., Lin, W.L., Dolios, G., Wang, R., Eckman, C.B., Dickson, D.W., Hutton, M., Hardy, J., Golde, T., Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47 (2005), 191–199.
65. Mehta, A.K., Rosen, R.F., Childers, W.S., Gehman, J.D., Walker, L.C., Lynn, D.G., Context dependence of protein misfolding and structural strains in neurodegenerative diseases. Biopolymers 100 (2013), 722–730.
66. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A.L., Vigouret, J.-M., Paganetti, P., Walsh, D.M., Mathews, P.M., Ghiso, J., Staufenbiel, M., Walker, L.C., Jucker, M., Exogenous induction of cerebral {beta}-amyloidogenesis is governed by agent and host. Science 313 (2006), 1781–1784.
67. Miravalle, L., Calero, M., Takao, M., Roher, A.E., Ghetti, B., Vidal, R., Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 44 (2005), 10810–10821.
68. Morales, R., Bravo-Alegria, J., Duran-Aniotz, C., Soto, C., Titration of biologically active amyloid-beta seeds in a transgenic mouse model of Alzheimer's disease. Sci. Rep., 5, 2015, 9349.
69. Morales, R., Duran-Aniotz, C., Castilla, J., Estrada, L.D., Soto, C., De novo induction of amyloid-beta deposition in vivo. Mol. Psychiatry 17 (2012), 1347–1353.
70. Morawski, M., Schilling, S., Kreuzberger, M., Waniek, A., Jager, C., Koch, B., Cynis, H., Kehlen, A., Arendt, T., Hartlage-Rubsamen, M., Demuth, H.U., Rossner, S., Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer's disease. J. Alzheimers Dis. 39 (2014), 385–400.
71. Morelli, L., Wei, L., Amorim, A., McDermid, J., Abee, C.R., Frangione, B., Walker, L.C., Levy, E., Cerebrovascular amyloidosis in squirrel monkeys and rhesus monkeys: apolipoprotein E genotype. FEBS Lett 379 (1996), 132–134.
72. Morrissette, D.A., Parachikova, A., Green, K.N., LaFerla, F.M., Relevance of transgenic mouse models to human Alzheimer disease. J. Biol. Chem. 284 (2009), 6033–6037.
73. Murray, M.M., Bernstein, S.L., Nyugen, V., Condron, M.M., Teplow, D.B., Bowers, M.T., Amyloid beta protein: abeta40 inhibits Abeta42 oligomerization. J. Am. Chem. Soc. 131 (2009), 6316–6317.
74. Nelson, P.T., Alafuzoff, I., Bigio, E.H., Bouras, C., Braak, H., Cairns, N.J., Castellani, R.J., Crain, B.J., Davies, P., Del Tredici, K., Duyckaerts, C., Frosch, M.P., Haroutunian, V., Hof, P.R., Hulette, C.M., Hyman, B.T., Iwatsubo, T., Jellinger, K.A., Jicha, G.A., Kovari, E., Kukull, W.A., Leverenz, J.B., Love, S., Mackenzie, I.R., Mann, D.M., Masliah, E., McKee, A.C., Montine, T.J., Morris, J.C., Schneider, J.A., Sonnen, J.A., Thal, D.R., Trojanowski, J.Q., Troncoso, J.C., Wisniewski, T., Woltjer, R.L., Beach, T.G., Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71 (2012), 362–381.
75. Nisbet, R.M., Polanco, J.C., Ittner, L.M., Gotz, J., Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol. 129 (2015), 207–220.
76. Nussbaum, J.M., Schilling, S., Cynis, H., Silva, A., Swanson, E., Wangsanut, T., Tayler, K., Wiltgen, B., Hatami, A., Ronicke, R., Reymann, K., Hutter-Paier, B., Alexandru, A., Jagla, W., Graubner, S., Glabe, C.G., Demuth, H.U., Bloom, G.S., Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 485 (2012), 651–655.
77. Pauwels, K., Williams, T.L., Morris, K.L., Jonckheere, W., Vandersteen, A., Kelly, G., Schymkowitz, J., Rousseau, F., Pastore, A., Serpell, L.C., Broersen, K., Structural basis for increased toxicity of pathological abeta42:abeta40 ratios in Alzheimer disease. J. Biol. Chem. 287 (2012), 5650–5660.
78. Perez, S.E., Raghanti, M.A., Hof, P.R., Kramer, L., Ikonomovic, M.D., Lacor, P.N., Erwin, J.M., Sherwood, C.C., Mufson, E.J., Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla). J. Comp. Neurol. 521 (2013), 4318–4338.
79. Petkova, A.T., Leapman, R.D., Guo, Z., Yau, W.M., Mattson, M.P., Tycko, R., Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307 (2005), 262–265.
80. Piccini, A., Russo, C., Gliozzi, A., Relini, A., Vitali, A., Borghi, R., Giliberto, L., Armirotti, A., D'Arrigo, C., Bachi, A., Cattaneo, A., Canale, C., Torrassa, S., Saido, T.C., Markesbery, W., Gambetti, P., Tabaton, M., Beta-amyloid is different in normal aging and in Alzheimer disease. J. Biol. Chem. 34 (2005), 186–192.
81. Pike, C.J., Overman, M.J., Cotman, C.W., Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J. Biol. Chem. 270 (1995), 23895–23898.
82. Portelius, E., Andreasson, U., Ringman, J.M., Buerger, K., Daborg, J., Buchhave, P., Hansson, O., Harmsen, A., Gustavsson, M.K., Hanse, E., Galasko, D., Hampel, H., Blennow, K., Zetterberg, H., Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol. Neurodegener., 5, 2010, 2.
83. Portelius, E., Bogdanovic, N., Gustavsson, M.K., Volkmann, I., Brinkmalm, G., Zetterberg, H., Winblad, B., Blennow, K., Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Acta Neuropathol. 120 (2010), 185–193.
84. Portelius, E., Lashley, T., Westerlund, A., Persson, R., Fox, N.C., Blennow, K., Revesz, T., Zetterberg, H., Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Neurodegener. Dis. 15 (2015), 50–57.
85. Portelius, E., Zetterberg, H., Andreasson, U., Brinkmalm, G., Andreasen, N., Wallin, A., Westman-Brinkmalm, A., Blennow, K., An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. Neurosci. Lett. 409 (2006), 215–219.
86. Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N. Engl. J. Med. 362 (2010), 329–344.
87. Revesz, T., Ghiso, J., Lashley, T., Plant, G., Rostagno, A., Frangione, B., Holton, J.L., Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J. Neuropathol. Exp. Neurol. 62 (2003), 885–898.
88. Roher, A.E., Palmer, K.C., Yurewicz, E.C., Ball, M.J., Greenberg, B.D., Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J. Neurochem. 61 (1993), 1916–1926.
89. Rosen, R.F., Ciliax, B.J., Wingo, T.S., Gearing, M., Dooyema, J., Lah, J.J., Ghiso, J.A., LeVine, H. 3rd, Walker, L.C., Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol. 119 (2010), 221–233.
90. Rosen, R.F., Farberg, A.S., Gearing, M., Dooyema, J., Long, P.M., Anderson, D.C., Davis-Turak, J., Coppola, G., Geschwind, D.H., Pare, J.F., Duong, T.Q., Hopkins, W.D., Preuss, T.M., Walker, L.C., Tauopathy with paired helical filaments in an aged chimpanzee. J. Comp. Neurol. 509 (2008), 259–270.
91. Rosen, R.F., Fritz, J.J., Dooyema, J., Cintron, A.F., Hamaguchi, T., Lah, J.J., LeVine, H. 3rd, Jucker, M., Walker, L.C., Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats. J. Neurochem. 120 (2012), 660–666.
92. Rosen, R.F., Tomidokoro, Y., Ghiso, J.A., Walker, L.C., SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval. J. Vis. Exp., 38, 2010, 1916.
93. Rosen, R.F., Walker, L.C., Levine, H. 3rd, PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol. Aging 32 (2011), 223–234.
94. Rufenacht, P., Guntert, A., Bohrmann, B., Ducret, A., Dobeli, H., Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry. J. Mass Spectrom. 40 (2005), 193–201.
95. Sawamura, N., Tamaoka, A., Shoji, S., Koo, E.H., Walker, L.C., Mori, H., Characterization of amyloid beta protein species in cerebral amyloid angiopathy of a squirrel monkey by immunocytochemistry and enzyme-linked immunosorbent assay. Brain Res. 764 (1997), 225–229.
96. Schlenzig, D., Manhart, S., Cinar, Y., Kleinschmidt, M., Hause, G., Willbold, D., Funke, S.A., Schilling, S., Demuth, H.U., Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry 48 (2009), 7072–7078.
97. Schlenzig, D., Ronicke, R., Cynis, H., Ludwig, H.H., Scheel, E., Reymann, K., Saido, T., Hause, G., Schilling, S., Demuth, H.U., N-Terminal pyroglutamate formation of Abeta38 and Abeta40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation. J. Neurochem. 121 (2012), 774–784.
98. Scholl, M., Wall, A., Thordardottir, S., Ferreira, D., Bogdanovic, N., Langstrom, B., Almkvist, O., Graff, C., Nordberg, A., Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology 79 (2012), 229–236.
99. Selkoe, D.J., Biology of beta-amyloid precursor protein and the mechanism of Alzheimer disease. Terry, R.D., Katzman, R., Bick, K.L., Sisodia, S.S., (eds.) Alzheimer Disease, 1999, Lippincott Williams and Wilkins, Philadelphia, 293–310.
100. Selkoe, D.J., Resolving controversies on the path to Alzheimer's therapeutics. Nat. Med. 17 (2011), 1060–1065.
101. Selkoe, D.J., Bell, D.S., Podlisny, M.B., Price, D.L., Cork, L.C., Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235 (1987), 873–877.
102. Serdons, K., Verduyckt, T., Vanderghinste, D., Cleynhens, J., Borghgraef, P., Vermaelen, P., Terwinghe, C., Van Leuven, F., Van Laere, K., Kung, H., Bormans, G., Verbruggen, A., Synthesis of 18F-labelled 2-(4′-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB. Bioorg. Med. Chem. Lett. 19 (2009), 602–605.
103. Simic, G., Babic Leko, M., Wray, S., Harrington, C., Delalle, I., Jovanov-Milosevic, N., Bazadona, D., Buee, L., de Silva, R., Di Giovanni, G., Wischik, C., Hof, P.R., Tau protein hyperphosphorylation and aggregation in Alzheimer's disease and other tauopathies, and possible neuroprotective strategies. Biomolecules, 6, 2016, 6.
104. Sperling, R.A., Karlawish, J., Johnson, K.A., Preclinical Alzheimer disease—the challenges ahead. Nat. Rev. Neurol. 9 (2013), 54–58.
105. Stohr, J., Condello, C., Watts, J.C., Bloch, L., Oehler, A., Nick, M., DeArmond, S.J., Giles, K., DeGrado, W.F., Prusiner, S.B., Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 10329–10334.
106. Stohr, J., Watts, J.C., Mensinger, Z.L., Oehler, A., Grillo, S.K., DeArmond, S.J., Prusiner, S.B., Giles, K., Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 11025–11030.
107. Struyfs, H., Van Broeck, B., Timmers, M., Fransen, E., Sleegers, K., Van Broeckhoven, C., De Deyn, P.P., Streffer, J.R., Mercken, M., Engelborghs, S., Diagnostic accuracy of cerebrospinal fluid amyloid-beta isoforms for early and differential dementia diagnosis. J. Alzheimers Dis. 45 (2015), 813–822.
108. Tekirian, T.L., Cole, G.M., Russell, M.J., Yang, F., Wekstein, D.R., Patel, E., Snowdon, D.A., Markesbery, W.R., Geddes, J.W., Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol. Aging 17 (1996), 249–257.
109. Tekirian, T.L., Saido, T.C., Markesbery, W.R., Russell, M.J., Wekstein, D.R., Patel, E., Geddes, J.W., N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J. Neuropathol. Exp. Neurol. 57 (1998), 76–94.
110. Tekirian, T.L., Yang, A.Y., Glabe, C., Geddes, J.W., Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42. J. Neurochem. 73 (1999), 1584–1589.
111. Tomidokoro, Y., Lashley, T., Rostagno, A., Neubert, T.A., Bojsen-Moller, M., Braendgaard, H., Plant, G., Holton, J., Frangione, B., Revesz, T., Ghiso, J., Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques. J. Biol. Chem. 280 (2005), 36883–36894.
112. Toyama, H., Ye, D., Ichise, M., Liow, J.S., Cai, L., Jacobowitz, D., Musachio, J.L., Hong, J., Crescenzo, M., Tipre, D., Lu, J.Q., Zoghbi, S., Vines, D.C., Seidel, J., Katada, K., Green, M.V., Pike, V.W., Cohen, R.M., Innis, R.B., PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 32 (2005), 593–600.
113. Walker, L.C., Callahan, M.J., Bian, F., Durham, R.A., Roher, A.E., Lipinski, W.J., Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 23 (2002), 1241–1247.
114. Walker, L.C., Cork, L.C., The neurobiology of aging in nonhuman primates. Terry, R.D., (eds.) Alzheimer Disease, 1999, Lippincott Williams and Wilkins, Philadelphia, PA, 233–243.
115. Walker, L.C., Kitt, C.A., Schwam, E., Buckwald, B., Garcia, F., Sepinwall, J., Price, D.L., Senile plaques in aged squirrel monkeys. Neurobiol. Aging 8 (1987), 291–296.
116. Walker, L.C., Masters, C., Beyreuther, K., Price, D.L., Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol. (Berl) 80 (1990), 381–387.
117. Walker, L.C., Pahnke, J., Madauss, M., Vogelgesang, S., Pahnke, A., Herbst, E.W., Stausske, D., Walther, R., Kessler, C., Warzok, R.W., Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly. Acta Neuropathol. 100 (2000), 36–42.
118. Watt, A.D., Perez, K.A., Rembach, A., Sherrat, N.A., Hung, L.W., Johanssen, T., McLean, C.A., Kok, W.M., Hutton, C.A., Fodero-Tavoletti, M., Masters, C.L., Villemagne, V.L., Barnham, K.J., Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples. Acta Neuropathol. 125 (2013), 549–564.
119. Watts, J.C., Condello, C., Stohr, J., Oehler, A., Lee, J., DeArmond, S.J., Lannfelt, L., Ingelsson, M., Giles, K., Prusiner, S.B., Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 10323–10328.
120. Watts, J.C., Giles, K., Grillo, S.K., Lemus, A., DeArmond, S.J., Prusiner, S.B., Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 2528–2533.
121. Wilhelmus, M.M., de Waal, R.M., Verbeek, M.M., Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer's disease. Mol. Neurobiol. 35 (2007), 203–216.
122. Ye, L., Fritschi, S.K., Schelle, J., Obermuller, U., Degenhardt, K., Kaeser, S.A., Eisele, Y.S., Walker, L.C., Baumann, F., Staufenbiel, M., Jucker, M., Persistence of Abeta seeds in APP null mouse brain. Nat. Neurosci. 18 (2015), 1559–1561.
123. Ye, L., Hamaguchi, T., Fritschi, S.K., Eisele, Y.S., Obermuller, U., Jucker, M., Walker, L.C., Progression of seed-induced abeta deposition within the limbic connectome. Brain Pathol. 25 (2015), 743–752.